Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

June 8, 2017

Primary Completion Date

February 18, 2021

Study Completion Date

November 19, 2021

Conditions
Pregnancy PretermNeonatal HypoglycemiaHyperglycemia Drug Induced
Interventions
OTHER

Maternal glycemic control

Maternal capillary blood glucose testing will be performed according to oral intake status: every 2 hours if not eating (NPO) or fasting and 1-hour postprandial if eating regular meals. Hyperglycemia, defined based on the American Diabetes Association and the American College of Obstetricians and Gynecologists recommendations as well as current practice at study sites, will be treated according to study guidelines based on oral intake status: insulin infusion if NPO and subcutaneous insulin if eating regular meals.

Trial Locations (2)

27599

University of North Carolina - Chapel Hill, Chapel Hill

35233

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT03076775 - Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study | Biotech Hunter | Biotech Hunter